Bristol Myers Squibb (BMY) Retained Earnings (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Retained Earnings data on file, last reported at -$1.4 billion in Q1 2026.

• Retained Earnings for Q1 2026 came in at -$1.4 billion, down 108.51% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.4 billion (down 108.51% YoY), and the FY2025 annual result was -$1.5 billion, down 23.1% from the prior year.
• Retained Earnings rose to -$1.4 billion in Q1 2026 per BMY's latest filing, from -$1.5 billion in the prior quarter.
• Over five years, Retained Earnings peaked at $25.5 billion in Q4 2022 and troughed at -$1.6 billion in Q2 2025.
• A 5-year average of $7.4 billion and a median of -$1.2 billion in 2024 frame the typical range for Retained Earnings.
• The sharpest annual moves came in 2024 and 2026: Retained Earnings surged 1351.71% in 2024, then plunged 108.51% in 2026.
• A 5-year view of Retained Earnings shows it stood at $25.5 billion in 2022, then plunged by 106.06% to -$1.5 billion in 2023, then increased by 19.92% to -$1.2 billion in 2024, then dropped by 23.1% to -$1.5 billion in 2025, then climbed by 10.1% to -$1.4 billion in 2026.
• Business Quant data shows BMY's Retained Earnings at -$1.4 billion in Q1 2026, -$1.5 billion in Q4 2025, and $17.1 billion in Q3 2025.